Aft Forsyth & Sober’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.61M Hold
9,750
1.41% 20
2025
Q4
$4.55M Hold
9,750
1.38% 20
2025
Q3
$4.16M Hold
9,750
1.29% 23
2025
Q2
$3.74M Hold
9,750
1.26% 21
2025
Q1
$3.37M Hold
9,750
1.17% 21
2024
Q4
$2.93M Hold
9,750
0.95% 28
2024
Q3
$3.96M Hold
9,750
1.3% 14
2024
Q2
$3.13M Hold
9,750
1.07% 23
2024
Q1
$3.25M Hold
9,750
1.15% 17
2023
Q4
$2.64M Hold
9,750
1.02% 18
2023
Q3
$2.4M Hold
9,750
1.01% 20
2023
Q2
$2.96M Buy
9,750
+900
+10% +$250K 1.23% 13
2023
Q1
$2.33M Sell
8,850
-900
-9% -$229K 1.18% 16
2022
Q4
$2.34M Hold
9,750
1.05% 17
2022
Q3
$1.79M Hold
9,750
0.87% 26
2022
Q2
$1.64M Hold
9,750
0.76% 32
2022
Q1
$2.44M Hold
9,750
0.96% 17
2021
Q4
$2.5M Buy
9,750
+300
+3% +$73.4K 0.88% 19
2021
Q3
$2.29M Buy
9,450
+2,350
+33% +$575K 0.86% 21
2021
Q2
$1.47M Hold
7,100
0.55% 37
2021
Q1
$1.34M Buy
7,100
+3,300
+87% +$582K 0.55% 37
2020
Q4
$625K Buy
3,800
+3,200
+533% +$468K 0.48% 21
2020
Q3
$75K Hold
600
0.58% 19
2020
Q2
$58K Hold
600
0.41% 31
2020
Q1
$54K Buy
+600
New +$77.7K 0.58% 18

Other funds holding HCA

Aft Forsyth & Sober's HCA Position: Q1 2026 in Review

Aft Forsyth & Sober held its HCA Healthcare (HCA) position steady in Q1 2026 at 9,750 shares worth $4.61M. The position accounts for 1.41% of the portfolio, ranked #20.

Aft Forsyth & Sober first reported a position in HCA in Q1 2020 and has held it in 25 quarters since. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Aft Forsyth & Sober held 9,750 shares of HCA Healthcare worth $4.61M as of Q1 2026.
  • Aft Forsyth & Sober left its HCA Healthcare share count unchanged in Q1 2026.
  • HCA Healthcare made up 1.41% of Aft Forsyth & Sober's portfolio in Q1 2026, its #20 holding.
  • Aft Forsyth & Sober first reported a position in HCA Healthcare in Q1 2020 and has held it in 25 quarters since.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Aft Forsyth & Sober's 13F filing for Q1 2026, filed 14 May 2026.